🔗 Share this article

Chancellor Reeves has revealed she is preparing "targeted steps to tackle household expense pressures" in the forthcoming financial statement.

In comments to media outlets, she noted that reducing price rises is a collective duty of both the government and the central bank.

The United Kingdom's price growth is expected to be the most elevated among the G7 advanced economies this calendar year and next.

Potential Energy Bill Interventions

Reports indicate the administration could intervene to lower energy bills, for example by reducing the present 5% level of value-added tax charged on energy.

A further approach is to reduce some of the policy costs currently included in bills.

Fiscal Constraints and Analyst Expectations

The administration will receive the latest report from the official forecaster, the OBR, on the start of the week, which will clarify how much room there is for these actions.

The consensus from the majority of analysts is that Reeves will have to introduce tax rises or budget cuts in order to adhere to her declared borrowing rules.

Previously on Thursday, calculations showed there was a twenty-two billion pound gap for the chancellor to fill, which is at the lower end of projections.

"It is a shared responsibility between the Bank of England and the administration to bear down further on some of the drivers of inflation," the Chancellor stated to reporters in Washington, at the annual meetings of the IMF and World Bank.

Revenue Pledges and Global Concerns

While a great deal of the attention has been on likely tax increases, the Treasury chief said the latest information from the OBR had not altered her pledge to manifesto promises not to increase tax levels on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable global environment" with increasing geopolitical and commercial tensions for the Budget tax moves, probably to be focused on those "most able to pay."

International Trade Disputes

Addressing worries about the UK's commercial links with the Asian nation she said: "Our security interests invariably come first."

Last week's declaration by Chinese authorities to tighten trade restrictions on critical minerals and other materials that are crucial for advanced tech manufacturing led American leader Donald Trump to propose an additional 100% import tax on goods from China, increasing the risk of an all-out commercial conflict between the two economic giants.

The American finance chief described the Chinese action "economic coercion" and "a international production control attempt."

Questioned on accepting the US offer to join its battle with China, the Chancellor said she was "deeply worried" by Chinese measures and urged the Chinese government "not to put up barriers and restrict access."

She said the move was "bad for the international commerce and creates further challenges."

"I believe there are sectors where we must confront Chinese policies, but there are also significant prospects to trade with Chinese markets, including banking sector and other areas of the economic system. We've got to get that balance right."

The Treasury chief also affirmed she was collaborating with international partners "on our own essential resources plan, so that we are less reliant."

Health Service Medicine Pricing and Funding

Reeves also recognized that the price the National Health Service spends on drugs could rise as a result of ongoing discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

A number of the biggest global drug companies have said recently that they are either pausing or scrapping investments in the United Kingdom, with some blaming the low prices they are obtaining.

Last month, the government science advisor said the price the health service spends on medicines would have to increase to halt businesses and drug research funding leaving the United Kingdom.

The Chancellor informed media: "We have seen as a result of the cost structure, that clinical trials, recent pharmaceuticals have not been available in the United Kingdom in the way that they are in other EU nations."

"We want to guarantee that people getting care from the NHS are can receive the finest life-saving treatments in the globe. And so we are reviewing all of that, and... looking to attract increased funding into the UK."